Pulmonary toxicities associated with the use of immune checkpoint inhibitors: An update from the immuno-oncology subgroup of the neutropenia, infection & …
BL Rapoport, VR Shannon, T Cooksley… - Frontiers in …, 2021 - frontiersin.org
The development of immune checkpoint inhibitors (ICIs) has revolutionized cancer
treatment, with agents such as nivolumab, pembrolizumab, and cemiplimab targeting …
treatment, with agents such as nivolumab, pembrolizumab, and cemiplimab targeting …
Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)
H Link - Supportive Care in Cancer, 2022 - Springer
Granulocyte colony-stimulating factor (G-CSF), a protein that stimulates the growth of new
blood cells, was isolated from human cells by Malcolm Moore and Karl Welte in 1984 [1]. It …
blood cells, was isolated from human cells by Malcolm Moore and Karl Welte in 1984 [1]. It …
Chinese expert consensus on intestinal microecology and management of digestive tract complications related to tumor treatment (version 2022)
J Wang, J Liang, M He, Q Xie, Q Wu… - Journal of Cancer …, 2022 - journals.lww.com
The human gut microbiota represents a complex ecosystem that is composed of bacteria,
fungi, viruses, and archaea. It affects many physiological functions including metabolism …
fungi, viruses, and archaea. It affects many physiological functions including metabolism …
Evaluation of burnout in a national sample of hematology-oncology pharmacists
AP Golbach, KB McCullough, SA Soefje… - JCO Oncology …, 2022 - ascopubs.org
PURPOSE: To evaluate the prevalence of burnout among hematology-oncology
pharmacists and factors associated with an increased risk of high burnout. METHODS …
pharmacists and factors associated with an increased risk of high burnout. METHODS …
A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a …
B Leon Rapoport, M Garcia-Morillo, C Font… - Supportive Care in …, 2023 - Springer
Purpose Limited knowledge is available on the incidence of febrile neutropenia (FN) in
intermediate-risk patients and the rationale for use of granulocyte colony-stimulating factor …
intermediate-risk patients and the rationale for use of granulocyte colony-stimulating factor …
Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study
PV Bhardwaj, M Emmich, A Knee, F Ali, R Walia… - Supportive Care in …, 2021 - Springer
Abstract Purpose The Multinational Association for Supportive Care in Cancer (MASCC)
score is used to risk stratify outpatients with febrile neutropenia (FN). However, it is rarely …
score is used to risk stratify outpatients with febrile neutropenia (FN). However, it is rarely …
G-CSF primary prophylaxis use and outcomes in patients receiving chemotherapy at intermediate risk for febrile neutropenia: a scoping review
K Campbell, N Chadha, S Dimri… - Expert Review of …, 2022 - Taylor & Francis
Introduction Febrile neutropenia (FN) is a major dose-limiting toxicity of myelosuppressive
chemotherapy, and several patients receiving chemotherapy are at intermediate risk of …
chemotherapy, and several patients receiving chemotherapy are at intermediate risk of …
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research
A Lasagna, M Muzzana, P Pedrazzoli - Immunotherapy, 2021 - Taylor & Francis
Since the early phase of the COVID-19 pandemic, a principal international panel of experts
from European Society for Medical Oncology (ESMO)[1] and Multinational Association of …
from European Society for Medical Oncology (ESMO)[1] and Multinational Association of …
COVID-19 and supportive cancer care: key issues and opportunities
FD Ashbury - Current Opinion in Oncology, 2021 - journals.lww.com
COVID-19 has seriously disrupted cancer treatment and supportive care for patients and
survivors. This paper highlights implications for clinical practice during and post-COVID-19 …
survivors. This paper highlights implications for clinical practice during and post-COVID-19 …
Neurological complications in oncology and their monitoring and management in clinical practice: a narrative review
S Fischer, M von Bonin, M Bornhäuser, C Beste… - Supportive Care in …, 2024 - Springer
Objectives This work aimed to provide an overview of the questions raised in the field of
clinical neuroscience that concern the outcomes of oncological diseases and their treatment …
clinical neuroscience that concern the outcomes of oncological diseases and their treatment …